Beckley Psytech

Developer of rapid-acting psychedelic medicines for mental health disorders

placeOxford, England, United Kingdom calendar_todayFounded 2019 groups1 employees language beckleypsytech.com

Registered entities

Social engagement

Social engagement: 9.3K social following, 7 posts in the last 12 months — below the industry typical range.

Investor mix

28 investors on record; lead investors include Integrated, ATAI, Noetic Psychedelic Fund, Bain Capital.

Investor typeCountShare
Venture capital1864%
Private equity311%
Other / undisclosed725%

Recent activity

5 Nov 2025
Partnership
atai Life Sciences
30 Oct 2025
Event
CNS Summit
17 Oct 2025
Milestone
regulatory
Coming soon